Portfolio moves
Net position changes between two of this fund's N-PORT snapshots. These are differences between point-in-time reports — not a trade log — and share counts can be affected by splits and other corporate actions.
Dec 31, 2025 → Mar 31, 2026
Expand a category to see the positions behind it, ranked by weight.
| Security | Shares Dec 2025 | Shares Mar 2026 | Δ shares | End % | Δ value |
|---|---|---|---|---|---|
| AXSOME THERAPEUTICS INC | 0 | 521,878 | 521,878 | 3.88% | $88.21M |
| BIO-TECHNE CORP | 0 | 1,227,575 | 1,227,575 | 2.82% | $64.15M |
| NEOGENOMICS INC | 0 | 6,128,278 | 6,128,278 | 2.00% | $45.47M |
| DAIWA CAPITAL MARKETS AMERICA INC | 0 | 188,488 | 188,488 | 0.01% | $188.49K |
| Security | Shares Dec 2025 | Shares Mar 2026 | Δ shares | End % | Δ value |
|---|---|---|---|---|---|
| EXACT SCIENCES CORP | 672,986 | 0 | -672,986 | 0.00% | -$68.35M |
| WATERS CORP | 118,620 | 0 | -118,620 | 0.00% | -$45.06M |
| METTLER-TOLEDO INTL INC | 30,826 | 0 | -30,826 | 0.00% | -$42.98M |
| U.S. Secured Overnight Financing Rate | 6,461,524 | 0 | -6,461,524 | 0.00% | -$6.46M |
| Security | Shares Dec 2025 | Shares Mar 2026 | Δ shares | End % | Δ value |
|---|---|---|---|---|---|
| MODERNA INC | 1,463,361 | 2,351,289 | 887,928 | 5.26% | $76.29M |
| UNITED THERAPEUTICS CORP DEL | 89,234 | 166,849 | 77,615 | 4.36% | $55.46M |
| ALKERMES PLC | 1,257,994 | 2,719,064 | 1,461,070 | 4.23% | $60.95M |
| GILEAD SCIENCES INC | 335,054 | 665,992 | 330,938 | 4.09% | $51.69M |
| AMGEN INC | 135,325 | 247,283 | 111,958 | 3.83% | $42.71M |
| CORCEPT THERAPEUTICS INC | 530,853 | 2,150,626 | 1,619,773 | 3.82% | $68.22M |
| KRYSTAL BIOTECH INC | 216,354 | 308,504 | 92,150 | 3.51% | $26.35M |
| BIOGEN INC | 267,876 | 429,853 | 161,977 | 3.47% | $31.66M |
| EXELIXIS INC | 1,029,501 | 1,831,270 | 801,769 | 3.46% | $33.42M |
| NEUROCRINE BIOSCIENCES INC | 287,363 | 593,926 | 306,563 | 3.44% | $37.49M |
| REGENERON PHARMACEUTICALS INC | 69,535 | 101,249 | 31,714 | 3.44% | $24.56M |
| VERTEX PHARMACEUTICALS INC | 96,277 | 173,834 | 77,557 | 3.42% | $33.98M |
| BIOMARIN PHARMACEUTICAL INC | 750,418 | 1,368,040 | 617,622 | 3.40% | $32.68M |
| ARGENX SE SPONSORED ADR | 49,268 | 102,325 | 53,057 | 3.29% | $33.29M |
| SAREPTA THERAPEUTICS INC | 1,776,478 | 3,384,344 | 1,607,866 | 3.24% | $35.41M |
| HALOZYME THERAPEUTICS INC | 612,510 | 1,112,843 | 500,333 | 3.17% | $30.70M |
| BIONTECH SE ADR | 384,694 | 807,711 | 423,017 | 3.16% | $35.17M |
| INCYTE CORP | 468,520 | 754,631 | 286,111 | 3.13% | $24.75M |
| BEONE MEDICINES LTD ADR | 122,657 | 238,672 | 116,015 | 3.12% | $33.61M |
| ILLUMINA INC | 418,360 | 571,731 | 153,371 | 3.10% | $15.60M |
| NATERA INC | 231,948 | 344,198 | 112,250 | 3.03% | $15.70M |
| ACADIA PHARMACEUTICALS INC | 1,957,224 | 3,011,495 | 1,054,271 | 2.95% | $14.76M |
| ALNYLAM PHARMACEUTICALS INC | 85,320 | 202,492 | 117,172 | 2.95% | $33.07M |
| GENMAB A/S -SP ADR DEPOSITARY RECEIPT | 1,234,265 | 2,354,019 | 1,119,754 | 2.78% | $25.14M |
| VERACYTE INC | 1,128,218 | 1,918,341 | 790,123 | 2.72% | $14.29M |
| REPLIGEN CORP | 270,328 | 483,433 | 213,105 | 2.51% | $12.66M |
| BRUKER CORP | 1,112,868 | 1,480,923 | 368,055 | 2.35% | $1.06M |
| DREY-GVT CSH-I | 959,084 | 1,413,994 | 454,910 | 0.06% | $454.91K |
No positions in this category.
No positions in this category.
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.